ArticleProbiotics and antimicrobial proteins2026
Effects of Compound Yeast Culture on the Intestinal Morphology, Intestinal Function, and Microorganisms of Weaned Lambs.
Article in Probiotics and antimicrobial proteins, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Yeast culture is a safe and environmentally friendly nutritional supplement that improves the antioxidant capacity, immune function, and intestinal health of monogastric animals. This study explored the effects of compound yeast culture and yeast source on the antioxidant capacity, immune function, and intestinal microflora of weaned lambs. Eighteen weaned lambs were randomly assigned to the basal diet (NYC), basal diet supplemented with yeast source (40 g/day; DYC), and basal diet supplemented with compound yeast culture (50 g/day; GYC) groups. There where six replicates per group and one lamb per replicate. The experiment lasted 42 d. The DYC and GYC groups exhibited significantly increased villus height and villus height-to-crypt depth ratio (P < 0.05), and the DYC group had reduced crypt depth (P < 0.05); both exhibited significantly increased glucagon-like peptide-2, Insulin-like growth factor 1, and mucin 2 mRNA expression, as well as serum total anti-oxidizing capability, glutathione peroxidase, total superoxide dismutase, and catalase activities (P < 0.05). The DYC and GYC groups exhibited significantly increased acid phosphatase (ACP) activity (P < 0.05), immunoglobulin G content, secretory immunoglobulin A content, and interleukin-10, transforming growth factor beta, B-cell activating factor, A proliferation-inducing ligand (APRIL), Chemokine ligand 25, Inducible NO synthase, and poly(lactic-co-glycolic acid) (plgA) mRNA expression (P < 0.05). The GYC group had significantly increased ACPcontent and APRIL and plgA mRNA expression (P < 0.05). Jejunal microbial markers in the DYC and GYC groups positively correlated with intestinal barrier-related indicators. In conclusion, the compound yeast culture and yeast source equally showed improved antioxidant capacity, immune function, and intestinal health in weaned lambs.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.